Amphastar Pharmaceuticals, Inc. (AMPH) vs Collegium Pharmaceutical, Inc. (COLL)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
Amphastar Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. are both Drug Manufacturers Specialty & Generic companies. Amphastar Pharmaceuticals, Inc. is the larger, with a market value of $1.1B against $754.6M — 1.5× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 15.2×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs 5.93%) and the lower return on invested capital (6.57% vs 7.85%). Across the 21 metrics below, Collegium Pharmaceutical, Inc. leads on 11 and Amphastar Pharmaceuticals, Inc. on 10.
Valuation
Profitability
| Metric | AMPH | COLL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 60.02% | 53.94% |
| Operating margin | 15.66% | 19.48% | 0.00% |
| Net margin | 10.76% | 5.93% | 0.00% |
| Free cash flow margin | 20.94% | 40.62% | 0.00% |
| Return on equity | 10.30% | 17.61% | (0.40%) |
| Return on assets | 4.68% | 2.57% | (3.32%) |
| Return on invested capital | 6.57% | 7.85% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack